NDAORALCAPSULE
Approved
Aug 1946
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 2d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
FOLVRON is a fixed-dose oral capsule combining ferrous sulfate (iron) and folic acid, used to treat and prevent iron deficiency anemia and folate deficiency. The iron component facilitates oxygen transport and hemoglobin synthesis, while folic acid supports red blood cell formation and DNA synthesis. This is a mature, well-established combination therapy with decades of clinical use.
LOE Approaching
Product nearing loss of exclusivity with moderate competitive pressure (30%), indicating a defensive commercial strategy and reduced team expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on FOLVRON offers limited career growth due to its mature, LOE-approaching lifecycle and absence of linked job postings. This role is best suited for professionals seeking stability in a defensive portfolio management environment rather than innovation or scale-up experience.
Brand ManagerField Sales Representative
Worked on FOLVRON at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.